IOVA
Iovance Biotherapeutics Inc
NASDAQ: IOVA · HEALTHCARE · BIOTECHNOLOGY
$3.36
+1.51% today
Updated 2026-04-30
Market cap
$1.41B
P/E ratio
—
P/S ratio
5.36x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$2 – $6
Volume
17.4M
Iovance Biotherapeutics Inc (IOVA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-0.3%
Last 4 quarters
Revenue YoY growth
+17.7%
Most recent quarter
EPS YoY growth
+30.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+9.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+27.1%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.18 | -2.0% | $2.77 | $2.52 | -9.0% |
| 2025-11-06 | $-0.25 | +4.5% | $1.81 | $2.30 | +27.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.18 | $-0.18 | -2.0% | $86.77M | +17.7% |
| 2025-09-30 | $-0.26 | $-0.25 | +4.5% | $67.45M | +15.2% |
| 2025-06-30 | $-0.28 | $-0.33 | -17.9% | $59.95M | +92.7% |
| 2025-03-31 | $-0.42 | $-0.36 | +14.3% | $49.32M | +6798.5% |
| 2024-12-31 | $-0.27 | $-0.26 | +2.8% | $73.69M | +15189.2% |
| 2024-09-30 | $-0.30 | $-0.28 | +6.7% | $58.55M | +12384.9% |
| 2024-06-30 | $-0.35 | $-0.34 | +2.9% | $31.11M | +12969.7% |
| 2024-03-31 | $-0.42 | $-0.42 | +0.0% | $715000.00 | — |
| 2023-12-31 | $-0.43 | $-0.45 | -4.7% | $482000.00 | — |
| 2023-09-30 | $-0.45 | $-0.46 | -2.2% | $469000.00 | — |
| 2023-06-30 | $-0.80 | $-0.47 | +41.3% | $238000.00 | — |
| 2023-03-31 | $-0.74 | $-0.50 | +32.4% | — | — |
Frequently asked questions
Has Iovance Biotherapeutics Inc beaten earnings estimates?
Iovance Biotherapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -0.3% over the last 4 quarters.
How does IOVA stock react to earnings?
IOVA stock has moved an average of +9.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Iovance Biotherapeutics Inc's revenue growth rate?
Iovance Biotherapeutics Inc reported year-over-year revenue growth of +17.7% in its most recent quarter, with EPS growing +30.8% year-over-year.